Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
This page features valuable insights into the Stock Market, covering topics like tariffs and dividend investing. Stay informed to enhance your investment strategies.
2,611 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
On a midweek Tuesday when tech stocks sagged, Salesforce bucked the trend. A fresh bullish note from a respected anal...
As policy moves accelerate quantum adoption, D-Wave and its peers spark trading activity. This deep dive explains wha...
A three-way market story unfolds: the Dow climbs, Nasdaq retreats, and SpaceX headlines keep investors guessing. Here...
On tesla stock dropped tuesday, shares slid as investors weighed delivery expectations and a cautious analyst note. T...
A broad pullback in the Magnificent Seven pushed the tech rally into a correction. Yet analysts say this may reflect ...
Arm Holdings has ridden a scorching AI-fueled rally in 2026, but today’s roughly 10% slide raises questions about mom...
A single, six-word Fed statement could reshape how investors price risk. This analysis explores the potential impact,...
As rates likely rise this year, stocks face a new environment. This guide breaks down what that means for the S&P 500...
Oil weakness adds pressure on Chevron as analysts weigh earnings visibility and cash returns. A rising risk of a drop...
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
PepsiCo stock faces a potential move toward $180 as analysts cite World Cup-driven demand, cost cuts, and internation...